Promega Biotechnology Research Award Supported by Promega Corporation, the Promega Biotechnology Research Award honors outstanding contributions to the application of biotechnology through fundamental microbiological research and development. Eligibility Criteria An outstanding contribution can be a single exceptionally significant achievement or the aggregate of a number of exemplary achievements. Award A cash prize of $5,000, a commemorative piece, and travel to the American Society for Microbiology General Meeting where the laureate delivers the Award Lecture. The award laureate and nominator are honored guests at the ASM awards banquet.
Nominations Nominations must be received by October 1. Nominations for the award should be an individual with expertise in biotechnology; no person may submit more than one nomination in any year. Neither self-nominations nor co-nominations will be accepted. Nominations will be considered without updating for three years. Nominations must consist of the following: Curriculum vitae, including a list of publications. Letter of nomination. Describe the nominee's outstanding accomplishments in microbiological research and development, including a list of the ten most relevant publications to the award. Letters of support. Two letters of support must come from persons, other than the nominator, who are familiar with the nominee's qualifications and accomplishments. No more than one of the three letters may be from the nominee's institution or the same institution. How to Submit Nominations Email nominee's CV. Email the letter of nomination. Ask two supporters to email their letters. Email all materials to awards@asmusa.org. Nomination materials will not be returned.
The Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several other biotech companies. The goal of the Gary Neil Prize for Innovation in Drug Development is to stimulate the application of innovative science to clinical drug development by recognizing outstanding individuals or teams who have been leaders in this area. Eligibility Individuals as well as teams from the pharmaceutical or biotechnology industry are eligible for the Gary Neil Prize for Innovation in Drug Development. The only requirement is that the candidate be a leader in the application of significant, innovative science to clinical drug development. Prize and Presentation The Gary Neil Prize for Innovation in Drug Development will be presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $2,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
For more information about the Gary Neil Prize for Innovation in Drug Development, please contact American Society for Clinical Pharmacology and Therapeutics (ASCPT) at (703) 836-6981 or info@ascpt.org.
Pharmaceutics > Research Starter GrantsProgramThe purpose of the PhRMA Foundation Research Starter Grants is to offer financial support to individuals beginning their independent research careers at the faculty level. The areas of interest within this program are research efforts in the fields of pharmaceutics. The program provides a research grant of $30,000 per year for up to two years.Research projects that extend or develop the proprietary value of specific drug products are not acceptable in this program. This exclusion does not preclude research in which specific drug products are used to test hypotheses that have a general applicability.For the purposes of this program, pharmaceutics includes basic pharmaceutics, biopharmaceutics, pharmaceutical technology and pharmaceutical biotechnology. The fundamental aspects of pharmacokinetics are not included since they are covered by PhRMA Foundation programs in pharmacology and toxicology. It is anticipated that this research experience will occur in an academic and/or industrial laboratory setting.The "starter" aspect of the program strives to assist those individuals who are establishing careers as independent investigators in the fields listed above. The program is not offered as a means to augment an ongoing research effort. Nor is the grant intended to be used for any direct effort to obtain further extramural funding. The funds are to be used to conduct the proposed research. This program supports individuals beginning independent research careers in academia who do not have other substantial sources of funding.Funds are generally unrestricted, with flexibility of use - a characteristic of the program. In an effort to gain the maximum usefulness, some guidelines are in order. The funds may not be used for salary support of the grantee, but may be used to support technical assistance. No more than $500 a year may be used for travel to professional meetings by the grantee. Indirect costs are not provided to the institution, and grant funds may not be used for this purpose.Applications, however good, which do not meet the aims of the program will be disapproved.EligibilityThose holding the academic, tenure track, rank of instructor or assistant professor and investigators at the doctoral level with equivalent positions are eligible to apply for these research starter grants, providing their proposed research is neither directly nor indirectly subsidized to any significant degree by an extramural support mechanism. Individuals holding non-tenure track positions, such as Research Assistant Professor or Visiting Assistant Professor, are not eligible to apply. The program is not intended for those in postdoctoral training programs. However, individuals in postdoctoral training scheduled to conclude, and who will hold an academic appointment, by January 1, 2008 may apply. Applicants must be sponsored by the department or unit within which the proposed research is to be undertaken. The grant is made to the university on behalf of the applicant and with the understanding that the university will administer the funds. Only schools of pharmacy are eligible for this award.Applications must be submitted by a school of pharmacy accredited by the American Council on Pharmaceutical Education, and all applicants must be U.S. citizens or permanent residents.Applicants will be judged on the scientific worthiness of the proposed research, and on the degree of need. If support is obtained after the application has been submitted, the Foundation must be so informed.Before an individual is eligible to apply for a PhRMA Foundation award, the applicant must first have a firm commitment from a U.S. university.
Application InformationApplications for research starter grant awards are to be submitted online October 1, 2008. Please note that no applications will be accepted after the deadline date.Awards to be made for the year beginning January 1, 2008 will be acknowledged no later than December 15, 2008.
1